Product NDC: | 0002-8770 |
Proprietary Name: | Humulin 70/30 |
Non Proprietary Name: | Insulin human |
Active Ingredient(s): | 100 [iU]/mL & nbsp; Insulin human |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-8770 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA019717 |
Marketing Category: | NDA |
Start Marketing Date: | 19990201 |
Package NDC: | 0002-8770-59 |
Package Description: | 5 SYRINGE in 1 CARTON (0002-8770-59) > 3 mL in 1 SYRINGE (0002-8770-01) |
NDC Code | 0002-8770-59 |
Proprietary Name | Humulin 70/30 |
Package Description | 5 SYRINGE in 1 CARTON (0002-8770-59) > 3 mL in 1 SYRINGE (0002-8770-01) |
Product NDC | 0002-8770 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Insulin human |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 19990201 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | INSULIN HUMAN |
Strength Number | 100 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes |